Trial intelligence / Profile preview

Bioequivalence study of generic azithromycin 250 mg tablet

TCTR20211222001Phase 1Completed

Sponsor
Duopharma Biotech
Start
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1 trial of azithromycin (2 arms), sponsored by Duopharma Biotech. Primary endpoint: Pharmacokinetics at 72.00 hours. Started Jul 2014; status: completed.

02

Drugs

azithromycin

Beyond the preview

Go deeper on TCTR20211222001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20211222001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call